Capital Raising through the Exercise of the Eighth Series of Stock Acquisition Rights
First written in FY2018-Q1. 17 of 20 entries say "Advanced", first in FY2018-Q3. Latest entry: 2026-08-05.
103 other companies' latest entry also says "Advanced".
- FY2024-Q1AdvancedAnnual report
「1 May 2023–31 July 2023 (Note 1) 23,000; 4,006,800; 7,895; 810,462; 7,895; 132,612 (Note 1) The increases resulted from the exercise of the Fifth and Ninth Series Stock Acquisition Rights.」
The exercise of the Fifth and Ninth Series Stock Acquisition Rights increased the number of shares by 23,000 during the quarter and increased share capital and capital reserve by ¥7.895 million each. - FY2023-Q2AdvancedAnnual report
「Number of convertible bonds with stock acquisition rights subject to exercise price adjustment exercised during the second quarter (units) 563 Number of shares delivered upon exercise during the quarter (shares) 56,300 Average exercise price, etc., for exercises during the quarter (¥) 1,125 Funds raised through exercises during the quarter (¥ thousands) 63,327」
The exercise of the Twelfth Series Stock Acquisition Rights progressed, with 563 rights and 56,300 shares exercised during the quarter, raising ¥63.327 million. Fundraising through the exercise of stock acquisition rights is making tangible progress. - FY2023-Q1AdvancedAnnual report
「During the cumulative first quarter, the exercise of stock acquisition rights (the Twelfth Series Stock Acquisition Rights, the 2020 ¥1 stock options and the 2021 ¥1 stock options) increased share capital and capital surplus by ¥91.169 million each. As a result, at the end of the first quarter, share capital was ¥769.120 million and capital surplus was ¥170.175 million.」
The exercise of the Twelfth Series Stock Acquisition Rights and other rights increased the number of issued shares by 134,800 and increased share capital and capital surplus by ¥91.169 million each. An additional 52,800 shares were issued in August following the exercise of 528 Twelfth Series Stock Acquisition Rights. - FY2022AdvancedAnnual report
「After the end of the fiscal year, the Twelfth Series Stock Acquisition Rights issued by the company on 7 April 2021 were exercised. The details of stock acquisition rights exercised between 1 May 2022 and 21 July 2022 are as follows.」
By the filing date, 1,308 of the Twelfth Series Stock Acquisition Rights had been exercised, increasing the number of shares by 130,800, share capital by ¥87.967 million, and capital reserve by ¥87.967 million. - FY2022-Q2AdvancedAnnual report
「Between 1 August 2021 and 31 October 2021, the exercise of the Ninth Series Stock Acquisition Rights increased the total number of issued shares by 100 and increased share capital and capital reserve by ¥102,000 each.」
The exercise of the Ninth Series Stock Acquisition Rights resulted in the issuance of 100 shares during the quarter and increased share capital and capital reserve by ¥102,000 each. - FY2021AdvancedAnnual report
「2 June 2020–20 April 2021: 18,200; 3,790,300; 18,883; 1,140,959; 18,883; 655,558」
The exercise of the Fifth, Sixth, Seventh, Ninth and Twelfth Series Stock Acquisition Rights increased the number of shares by 18,200 and increased share capital and capital reserve by ¥18.883 million each. In addition, the company newly issued the Twelfth through Fourteenth Series Stock Acquisition Rights and established a financing facility for a total of 681,500 underlying shares. - FY2021-Q3AdvancedAnnual report
「1 November 2020–31 January 2021 (Note) 3,600 3,790,200 3,581 1,140,845 3,581 655,444 (Note) The increases resulted from the exercise of the Fifth, Sixth, Seventh and Ninth Series Stock Acquisition Rights.」
The exercise of the Fifth, Sixth, Seventh and Ninth Series Stock Acquisition Rights increased the number of shares by 3,600 during the quarter and increased share capital and capital reserve by ¥3.581 million each. - FY2021-Q2AdvancedAnnual report
「1 August 2020–31 October 2020 (Note): 3,800; 3,786,600; 3,906; 1,137,263; 3,906; 651,863」
The exercise of stock acquisition rights resulted in the issuance of 3,800 shares during the quarter and increased share capital and capital reserve by ¥3.906 million each. - FY2021-Q1AdvancedAnnual report
「1 May 2020–31 July 2020: Change in total number of issued shares (shares) 10,700; change in share capital (¥ thousands) 11,281; change in capital reserve (¥ thousands) 11,281. Note: The increases resulted from the exercise of the Fifth, Sixth and Ninth Series Stock Acquisition Rights.」
The exercise of the Fifth, Sixth and Ninth Series Stock Acquisition Rights increased the number of shares by 10,700 during the quarter and increased share capital and capital reserve by ¥11.281 million each. - FY2020AdvancedAnnual report
「Funds provided by financing activities amounted to ¥1,110 million, compared with ¥52 million used in the previous consolidated fiscal year. This was mainly attributable to ¥575 million in proceeds from the issuance of shares through the exercise of stock acquisition rights, ¥343 million in proceeds from the net change in short-term borrowings, and ¥369 million in proceeds from long-term borrowings.」
During the consolidated fiscal year, the exercise of stock acquisition rights increased the number of shares by 470,300 and increased share capital and capital reserve by ¥296.625 million each. Capital raising progressed substantially from the previous fiscal year. - FY2020-Q3AdvancedAnnual report
「During the cumulative third quarter, the exercise of stock acquisition rights (the Fifth, Sixth and Tenth Series Stock Acquisition Rights) increased share capital and capital surplus by ¥288.258 million each. As a result, at the end of the third quarter, share capital was ¥1,113.708 million and capital surplus was ¥714.242 million.」
The exercise of the Fifth, Sixth and Tenth Series Stock Acquisition Rights increased share capital and capital surplus by ¥288.258 million each. The number of issued shares also increased by 454,700 during the third quarter. - FY2020-Q2AdvancedAnnual report
「Between the end of the cumulative second quarter and 30 November 2019, 3,356 of the 4,400 Tenth Series Stock Acquisition Rights allotted on 31 October 2017 to THE KENKOU FUTURE Investment Limited Partnership, for which With Partners Co., Ltd. serves as the managing partner, were exercised.」
Of the 4,400 Tenth Series Stock Acquisition Rights, 3,356 were exercised, increasing common shares by 335,600, share capital by ¥213.659 million, and capital reserve by ¥213.659 million. Fundraising through existing stock acquisition rights is making tangible progress. - FY2020-Q1AdvancedAnnual report
「Change in total number of issued shares (shares) 4,200; change in share capital (¥ thousands) 1,352; change in capital reserve (¥ thousands) 1,352. Note: The increases resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 4,200 during the quarter and increased share capital and capital reserve by ¥1.352 million each. Fundraising through the exercise of existing stock acquisition rights is progressing. - FY2019-Q3AdvancedAnnual report
「This was an increase resulting from the exercise of stock acquisition rights (the Fifth Series Stock Acquisition Rights).」
The Fifth Series Stock Acquisition Rights were exercised between 1 November 2018 and 31 January 2019, increasing the number of issued shares by 500 and share capital and capital reserve by ¥160,000 each. In addition, by the filing date, the exercise of the same stock acquisition rights had increased the number of shares by 4,600 and share capital and capital reserve by ¥1.480 million each. - FY2018AdvancedAnnual report
「Funds provided by financing activities amounted to ¥680 million. This was mainly attributable to ¥558 million in proceeds from the issuance of shares through the exercise of stock acquisition rights, ¥495 million in proceeds from the issuance of bonds, and ¥376 million in expenditure for the acquisition of shares in a subsidiary without a change in the scope of consolidation.」
Proceeds from the issuance of shares through the exercise of stock acquisition rights amounted to ¥558 million, while share capital and capital surplus each increased by ¥285 million. - FY2018-Q3AdvancedAnnual report
「During the cumulative third quarter, the exercise of stock acquisition rights (the Fifth and Eighth Series Stock Acquisition Rights and the 2017 stock options) increased share capital and capital surplus by ¥284.499 million each. As a result, at the end of the third quarter, share capital was ¥822.327 million and capital surplus was ¥422.860 million.」
The exercise of the Fifth and Eighth Series Stock Acquisition Rights and the 2017 stock options progressed, increasing share capital and capital surplus by ¥284.499 million each. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter, the exercise of stock acquisition rights (the Fifth and Eighth Series Stock Acquisition Rights) increased share capital and capital surplus by ¥273.616 million each.」
The exercise of the Fifth and Eighth Series Stock Acquisition Rights increased share capital and capital surplus by ¥273.616 million each. Fundraising through the exercise of existing stock acquisition rights is continuing. - FY2018-Q1First statedAnnual report
「During the cumulative first quarter, the exercise of stock acquisition rights (the Eighth Series Stock Acquisition Rights) increased share capital and capital surplus by ¥273.294 million each. As a result, at the end of the cumulative first quarter, share capital was ¥811.122 million and capital surplus was ¥411.656 million.」
The exercise of the Eighth Series Stock Acquisition Rights resulted in the delivery of 545,000 shares and raised ¥544 million. Share capital and capital surplus each increased by ¥273.294 million.